Article
<i>De novo</i> design of a safe and potent respiratory syncytial virus immuno-focusing antigen
2026-01-29
Abstract excerpt
<h4>SUMMARY</h4> Respiratory syncytial virus (RSV) remains the leading cause of severe respiratory infections in infants, the elderly, and the immunocompromised. Although stabilized full-length pre-fusion (pre-F) protein vaccines are promising, enhanced respiratory disease (ERD) remains a critical safety concern. Here, we used artificial intelligence to design a de novo immuno-focused antigen that structurally p...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f17ca7e5-b215-5ff2-82c7-bdef76eb3c2b
- DOI
- 10.64898/2026.01.28.702448
